re: accumulation Yes it was a long time ago that they first tried at China:
http://www.asx.com.au/asxpdf/20060704/pdf/3xf4f7cypl43g.pdf
http://www.asx.com.au/asxpdf/20061109/pdf/3zhkndgkwrnr4.pdf
This was when the share price was in the 40c range and over 200m(?) fully diluted shares on issue (not sure what the options prices were).
I am not a long term investor- I am a short termer. I see value in short term potential, such as the fact that the product may never make profits, but along the way there will be various value-adding announcements.
If they can change the prototype modelling, get a Chinese third party on board (which they have) then if claw back a small percentage of where the market cap was back in 2006, there will be value added for current shareholders.
http://www.asx.com.au/asxpdf/20130820/pdf/42hshbts5rbpwj.pdf
This above doesn't take into account the new therapeutic company acquisition which adds a totally different dimension to SBN but reflects their focus of close-to-commercialisation products.
IMO reviving the Oraline product is definitely worth a shot.
- Forums
- ASX - By Stock
- SBN
- re: accumulation
re: accumulation, page-12
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)